Selective transcriptional regulations in the human liver cell by hepatitis B viral X protein

Biochemical and Biophysical Research Communications

Volumn 272, Issue 2, 2000, Pages 525-530

  Han, Jaeseok ^a   Yoo, Hae Yong ^a   Choi, Byung Hyune ^a   Rho, Hyune Mo ^a  

^a Seoul National University   (South Korea)

Author keywords

cDNA microarray; HBx; Selective transcriptional regulation

Indexed keywords

COMPLEMENTARY DNA; MONOCYTE CHEMOTACTIC PROTEIN 1; THROMBIN RECEPTOR; TRANSCRIPTION FACTOR; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CELL STRAIN HEPG2; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

HEPATITIS B VIRUS;

EID: 0034616643     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2801     Document Type: Article

References (33)

1. Andrisani O. M., Barnabas S. The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis (Review). Int. J. Oncol. 15:1999;373-379.
2. Koike K., Moriya K., Yotsuyanagi H., Iino S., Kurokawa K. Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. J. Clin. Invest. 94:1994;44-49.
3. Benn J., Schneider R. J. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc. Natl. Acad. Sci. USA. 92:1995;11215-11219.
4. Sirma H., Giannini C., Poussin K., Paterlini P., Kremsdorf D., Brechot C. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene. 18:1999;4848-4859.
5. Wang X. W., Gibson M. K., Vermeulen W., Yeh H., Forrester K., Sturzbecher H. W., Hoeijmakers J. H., Harris C. C. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res. 55:1995;6012-6016.
6. Chirillo P., Pagano S., Natoli G., Puri P. L., Burgio V. L., Balsano C., Levrero M. The hepatitis B virus X gene induces p53-mediated programmed cell death. Proc. Natl. Acad. Sci. USA. 94:1997;8162-8167.
7. Terradillos O., Pollicino T., Lecoeur H., Tripodi M., Gougeon M. L., Tiollais P., Buendia M. A. p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene. 17:1998;2115-2123.
8. Lee S. G., Rho H. M. Transcriptional repression of the human p53 gene by hepatitis B viral X protein. Oncogene. 19:2000;468-471.
9. Brown P. O., Botstein D. Exploring the new world of the genome with DNA microarrays. Nat. Genet. 21:1999;33-37.
10. Lipshutz R. J., Fodor S. P., Gingeras T. R., Lockhart D. J. High density synthetic oligonucleotide arrays. Nat. Genet. 21:1999;20-24.
11. Lennon G. G., Lehrach H. Hybridization analyses of arrayed cDNA libraries. Trends Genet. 7:1991;314-317.
12. DeRisi J. L., Iyer V. R., Brown P. O. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science. 278:1997;680-686.
13. Iyer V. R., Eisen M. B., Ross D. T., Schuler G., Moore T., Lee J. C. F., Trent J. M., Staudt L. M., Hudson J. Jr., Boguski M. S., Lashkari D., Shalon D., Botstein D., Brown P. O. The transcriptional program in the response of human fibroblasts to serum. Science. 283:1999;83-87.
14. Choi C. Y., Choi B. H., Park G. T., Rho H. M. Activating transcription factor 2 (ATF2) down-regulates hepatitis B virus X promoter activity by the competition for the activating protein 1 binding site and the formation of the ATF2-Jun heterodimer. J. Biol. Chem. 272:1997;16934-16939.
15. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
16. Choi B. H., Park G. T., Rho H. M. Interaction of hepatitis B viral X protein and CCAAT/enhancer-binding protein alpha synergistically activates the hepatitis B viral enhancer II/pregenomic promoter. J. Biol. Chem. 274:1999;2858-2865.
17. Cross J. C., Wen P., Rutter W. J. Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. Proc. Natl. Acad. Sci. USA. 90:1993;8078-8082.
18. Datto M. B., Hu P. P., Kowalik T. F., Yingling J., Wang X. F. The viral oncoprotein E1A blocks transforming growth factor beta-mediated induction of p21/WAF1/Cip1 and p15/INK4B. Mol. Cell. Biol. 17:1997;2030-2037.
19. Uchida T., Takahashi K., Tatsuno K., Dhingra U., Eliason J. F. Inhibition of hepatitis-B-virus core promoter by p53: Implications for carcinogenesis in hepatocytes. Int. J. Cancer. 67:1996;892-897.
20. Luo L., Jan L. Y., Jan Y. N. Rho family GTP-binding proteins in growth cone signaling. Curr. Opin. Neurobiol. 7:1997;81-86.
21. Dennis P. A., Rifkin D. B. Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc. Natl. Acad. Sci. USA. 88:1991;580-584.
22. Yoo Y. D., Ueda H., Park K., Flanders K. C., Lee Y. I., Jay G., Kim S. J. Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis. J. Clin. Invest. 97:1996;388-395.
23. Taylor I. C., Roy S., Yaswen P., Stampfer M. R., Varmus H. E. Mouse mammary tumors express elevated levels of RNA encoding the murine homology of SKY, a putative receptor tyrosine kinase. J. Biol. Chem. 270:1995;6872-6880.
24. Weinstein J., Karim J., Geschwind D. H., Nelson S. F., Krumm J., Sakamoto K. M. Genomic organization, 5′ flanking enhancer region, and chromosomal assignment of the cell cycle gene, p55Cdc. Mol. Genet. Metab. 64:1998;52-57.
25. Nehlin J. O., Hara E., Kuo W. L., Collins C., Campisi J. Genomic organization, sequence, and chromosomal localization of the human helix-loop-helix Id1 gene. Biochem. Biophys. Res. Commun. 231:1997;628-634.
26. Fernandes-Alnemri T., Armstrong R. C., Krebs J., Srinivasula S. M., Wang L., Bullrich F., Fritz L. C., Trapani J. A., Tomaselli K. J., Litwack G., Alnemri E. S. In vitro. 93:1996;7464-7469.
27. Tian Q., Taupin J., Elledge S., Robertson M., Anderson P. Fas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis. J. Exp. Med. 182:1995;865-874.
28. Chittenden T., Harrington E. A., O'Connor R., Flemington C., Lutz R. J., Evan G. I., Guild B. C. Induction of apoptosis by the Bcl-2 homologue Bak. Nature. 374:1995;733-736.
29. Chen G., Ray R., Dubik D., Shi L., Cizeau J., Bleackley R. C., Saxena S., Gietz R. D., Greenberg A. H. The E1B 19K/Bcl-2-binding protein Nip3 is a dimeric mitochondrial protein that activates apoptosis. J. Exp. Med. 186:1997;1975-1983.
30. Yasuda M., Theodorakis P., Subramanian T., Chinnadurai G. Adenovirus E1B-19K/BCL-2 interacting protein BNIP3 contains a BH3 domain and a mitochondrial targeting sequence. J. Biol. Chem. 273:1998;12415-12421.
31. Hu K. Q., Yu C. H., Vierling J. M. Up-regulation of intercellular adhesion molecule 1 transcription by hepatitis B virus X protein. Proc. Natl. Acad. Sci. USA. 89:1992;11441-11445.
32. Ozturk M. Genetic aspects of hepatocellular carcinogenesis. Semin. Liver. Dis. 19:1999;235-242.
33. Steinhusen U., Badock V., Bauer A., Behrens J., Wittmann-Liebold B., Dorekn B., Bommert K. Apoptosis-induced cleavage of {beta}-catenin by caspase-3 results in proteolytic fragments with reduced transactivation potential. J. Biol. Chem. 2000.